Skip to main content

Advertisement

SpringerLink
Log in

HBV, antivirals, and immunoglobulins after liver transplantation: all that glitters is not gold

  • Letter to the Editor
  • Published:
Hepatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sheng LP, Zhang JC, Zhong ZQ, Sheng XH, Ren J, Wang GQ. High-potency nucleos(t)ide analogues alone or plus immunoglobulin for HBV prophylaxis after liver transplantation: a meta-analysis. Hepatol Int. 2023. https://doi.org/10.1007/s12072-022-10466-w. (Online ahead of print)

    Article  PubMed  Google Scholar 

  2. Lai Q, Mennini G, Giovanardi F, Rossi M, Giannini EG. Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: a meta-analysis. Eur J Clin Invest. 2021;51(8):13575. https://doi.org/10.1111/eci.13575. (Epub 2021 May 3)

    Article  CAS  Google Scholar 

  3. Duvoux C, Belli LS, Fung J, Angelico M, Buti M, Coilly A, et al. 2020 position statement and recommendations of the European liver and intestine transplantation association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation. Aliment Pharmacol Ther. 2021;54(5):583–605

    Article  PubMed  Google Scholar 

  4. Fung J, Chan SC, Cheung C, Yuen MF, Chok KS, Sharr W, et al. Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B. Am J Gastroenterol. 2013;108(6):942–948. https://doi.org/10.1038/ajg.2013

    Article  CAS  PubMed  Google Scholar 

  5. Muthiah MD, Tan EY, Chua SHM, Huang DQY, Bonney GK, Kow AWC, et al. Nucleoside analog monotherapy for prophylaxis in hepatitis B liver transplant patients is safe and efficacious. Hepatol Int. 2020;14(1):57–69

    Article  PubMed  Google Scholar 

  6. Liu Y, Ho WI, Deng F, Peng S, Lau WY, Chen H. Entecavir monotherapy prevents hepatitis B virus recurrence after liver transplant for chronic hepatitis B patients: a long-term retrospective study. Transplant Proc. 2021;53(5):1700–1706

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

    Edoardo G. Giannini

  2. General Surgery and Organ Transplantation Unit, Department of General and Specialty Surgery, Sapienza University of Rome, AOU Policlinico Umberto I of Rome, Viale del Policlinico 155, 00161, Rome, Italy

    Quirino Lai

Authors
  1. Edoardo G. Giannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Quirino Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Quirino Lai.

Ethics declarations

Conflict of interest

The Edoardo G. Giannini and Quirino Lai have no conflict of interest to declare.

Ethical approval

The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giannini, E.G., Lai, Q. HBV, antivirals, and immunoglobulins after liver transplantation: all that glitters is not gold. Hepatol Int 17, 1324–1325 (2023). https://doi.org/10.1007/s12072-023-10499-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-023-10499-9

Search

Navigation